• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性膀胱切除术治疗先前部分膀胱切除术后复发性尿路上皮癌:围手术期和肿瘤学结果。

Radical cystectomy for recurrent urothelial carcinoma after prior partial cystectomy: perioperative and oncologic outcomes.

机构信息

Department of Urology, Mayo Clinic, 200 1st St. SW, Rochester, MN, 55905, USA.

Department of Health Sciences Research, Rochester, MN, USA.

出版信息

World J Urol. 2017 Dec;35(12):1879-1884. doi: 10.1007/s00345-017-2087-4. Epub 2017 Sep 14.

DOI:10.1007/s00345-017-2087-4
PMID:28913657
Abstract

PURPOSE

To evaluate perioperative and oncologic outcomes of patients undergoing radical cystectomy (RC) for recurrence of urothelial carcinoma (UC) after prior partial cystectomy (PC), and to compare these outcomes to patients undergoing primary RC.

METHODS

Patients who underwent RC for recurrence of UC after prior PC were matched 1:3 to patients undergoing primary RC based on age, pathologic stage, and decade of surgery. Perioperative and oncologic outcomes were compared using Wilcoxon sign-rank test, McNemars test, the Kaplan-Meier method, and Cox proportional hazards regression analyses.

RESULTS

Overall, the cohorts were well matched on clinical and pathological characteristics. No difference was noted in operative time (median 322 versus 303 min; p = 0.41), estimated blood loss (median 800 versus 700 cc, p = 0.10) or length of stay (median 9 versus 10 days; p = 0.09). Similarly, there were no differences in minor (51.7 versus 44.3%; p = 0.32) or major (10.3 versus 12.6%; p = 0.66) perioperative complications. Median follow-up after RC was 5.0 years (IQR 1.5, 13.1 years). Notably, CSS was significantly worse for patients who underwent RC after PC (10 year-46.8 versus 65.9%; p = 0.03). On multivariable analysis, prior PC remained independently associated with an increased risk of bladder cancer death (HR 2.28; 95% CI 1.17, 4.42).

CONCLUSIONS

RC after PC is feasible, without significantly adverse perioperative outcomes compared to patients undergoing primary RC. However, the risk of death from bladder cancer may be higher, suggesting the need for careful patient counseling prior to PC and the consideration of such patients for adjuvant therapy after RC.

摘要

目的

评估先前接受过部分膀胱切除术(PC)的患者因尿路上皮癌(UC)复发而行根治性膀胱切除术(RC)的围手术期和肿瘤学结果,并将这些结果与初次接受 RC 的患者进行比较。

方法

根据年龄、病理分期和手术年代,将先前接受 PC 后因 UC 复发而行 RC 的患者与初次接受 RC 的患者进行 1:3 匹配。使用 Wilcoxon 符号秩检验、McNemar 检验、Kaplan-Meier 方法和 Cox 比例风险回归分析比较围手术期和肿瘤学结果。

结果

总体而言,两组在临床和病理特征上匹配良好。手术时间(中位数 322 与 303 分钟;p=0.41)、估计失血量(中位数 800 与 700cc;p=0.10)或住院时间(中位数 9 与 10 天;p=0.09)无差异。同样,轻微(51.7%与 44.3%;p=0.32)或主要(10.3%与 12.6%;p=0.66)围手术期并发症也无差异。RC 后中位随访时间为 5.0 年(IQR 1.5,13.1 年)。值得注意的是,PC 后行 RC 的患者 CSS 明显较差(10 年-46.8%与 65.9%;p=0.03)。多变量分析显示,先前的 PC 仍然与膀胱癌死亡风险增加独立相关(HR 2.28;95%CI 1.17,4.42)。

结论

PC 后行 RC 是可行的,与初次接受 RC 的患者相比,围手术期结果没有明显的不良影响。然而,膀胱癌死亡的风险可能更高,这表明在 PC 前需要对患者进行仔细的咨询,并考虑对 PC 后患者进行辅助治疗。

相似文献

1
Radical cystectomy for recurrent urothelial carcinoma after prior partial cystectomy: perioperative and oncologic outcomes.根治性膀胱切除术治疗先前部分膀胱切除术后复发性尿路上皮癌:围手术期和肿瘤学结果。
World J Urol. 2017 Dec;35(12):1879-1884. doi: 10.1007/s00345-017-2087-4. Epub 2017 Sep 14.
2
Postoperative Outcomes After Radical Cystectomy in Patients With Prior Pelvic Radiation.既往盆腔放疗患者根治性膀胱切除术后的术后结局
Urology. 2018 Jun;116:131-136. doi: 10.1016/j.urology.2018.01.001. Epub 2018 Mar 12.
3
Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis.根治性膀胱切除术治疗微乳头状膀胱癌与纯尿路上皮癌的结果:匹配队列分析。
World J Urol. 2012 Dec;30(6):801-6. doi: 10.1007/s00345-012-0976-0. Epub 2012 Nov 7.
4
Restrictive transfusion in radical cystectomy is safe.根治性膀胱切除术中限制性输血是安全的。
Urol Oncol. 2017 Aug;35(8):528.e15-528.e21. doi: 10.1016/j.urolonc.2017.04.001. Epub 2017 May 2.
5
Oncologic outcomes following robot-assisted radical cystectomy with minimum 5-year follow-up: the Roswell Park cancer institute experience.根治性膀胱切除术机器人辅助治疗后 5 年以上的肿瘤学结果:罗切斯特大学癌症研究所的经验。
Eur Urol. 2014 Nov;66(5):920-8. doi: 10.1016/j.eururo.2014.03.015. Epub 2014 Apr 16.
6
Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.根治性膀胱切除术治疗的膀胱癌患者,术前中性粒细胞与淋巴细胞比值与晚期病理肿瘤分期和癌症特异性死亡率增加相关。
Eur Urol. 2014 Dec;66(6):1157-64. doi: 10.1016/j.eururo.2014.02.042. Epub 2014 Feb 26.
7
Risk factors and outcomes of urethral recurrence following radical cystectomy.根治性膀胱切除术后尿道复发的风险因素和结果。
Eur Urol. 2011 Dec;60(6):1266-72. doi: 10.1016/j.eururo.2011.08.030. Epub 2011 Aug 22.
8
Factors influencing the length of stay after radical cystectomy: implications for cancer care and perioperative management.影响根治性膀胱切除术后住院时间的因素:对癌症护理和围手术期管理的启示
Ann Surg Oncol. 2014 Dec;21(13):4383-9. doi: 10.1245/s10434-014-3877-1. Epub 2014 Jul 22.
9
Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy.根治性膀胱切除术中扩大盆腔淋巴结清扫术的风险与获益平衡
World J Urol. 2016 Jan;34(1):41-8. doi: 10.1007/s00345-015-1734-x. Epub 2015 Nov 30.
10
The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy.浆细胞样变异型组织学对根治性膀胱切除术后膀胱癌患者生存的影响。
Eur Urol Focus. 2019 Jan;5(1):104-108. doi: 10.1016/j.euf.2017.06.013. Epub 2017 Jun 27.

本文引用的文献

1
Performance of partial cystectomy in the United States from 2001 to 2010: trends and comparative outcomes.2001年至2010年美国部分膀胱切除术的实施情况:趋势及比较结果
Can J Urol. 2014 Dec;21(6):7520-7.
2
Peri-operative morbidity associated with radical cystectomy in a multicenter database of community and academic hospitals.在一个社区和学术医院的多中心数据库中,与根治性膀胱切除术相关的围手术期发病率。
PLoS One. 2014 Oct 31;9(10):e111281. doi: 10.1371/journal.pone.0111281. eCollection 2014.
3
In-hospital death and hospital-acquired complications among patients undergoing partial cystectomy for bladder cancer in the United States.
美国膀胱癌患者接受部分膀胱切除术后的院内死亡和医院获得性并发症
Urol Oncol. 2014 Jan;32(1):53.e9-14. doi: 10.1016/j.urolonc.2013.08.024. Epub 2013 Nov 13.
4
Progression to detrusor muscle invasion during urothelial carcinoma surveillance is associated with poor prognosis.在尿路上皮癌监测过程中进展为逼尿肌浸润与预后不良相关。
BJU Int. 2014 Jun;113(6):900-6. doi: 10.1111/bju.12403. Epub 2013 Nov 27.
5
Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base.美国肌肉浸润性膀胱癌潜在治愈疗法的使用:来自国家癌症数据库的结果。
Eur Urol. 2013 May;63(5):823-9. doi: 10.1016/j.eururo.2012.11.015. Epub 2012 Nov 19.
6
Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy.部分膀胱切除术治疗后复发的膀胱尿路上皮癌行挽救性根治性膀胱切除术的长期结果。
BJU Int. 2013 Mar;111(3 Pt B):E37-42. doi: 10.1111/j.1464-410X.2012.11438.x. Epub 2012 Sep 14.
7
Does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis.与根治性膀胱切除术相比,部分膀胱切除术是否会影响膀胱癌患者的肿瘤学结果?一项匹配的病例对照分析。
J Urol. 2012 Oct;188(4):1115-9. doi: 10.1016/j.juro.2012.06.029. Epub 2012 Aug 15.
8
Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review.高危非肌肉浸润性膀胱癌患者肿瘤进展后的长期癌症特异性生存:系统评价。
Eur Urol. 2011 Sep;60(3):493-500. doi: 10.1016/j.eururo.2011.05.045. Epub 2011 Jun 1.
9
Treatment of muscle invasive bladder cancer: evidence from the National Cancer Database, 2003 to 2007.肌层浸润性膀胱癌的治疗:来自 2003 至 2007 年国家癌症数据库的证据。
J Urol. 2011 Jan;185(1):72-8. doi: 10.1016/j.juro.2010.09.015. Epub 2010 Nov 12.
10
Practice patterns and recurrence after partial cystectomy for bladder cancer.膀胱癌部分膀胱切除术的治疗模式和复发情况。
World J Urol. 2010 Aug;28(4):419-23. doi: 10.1007/s00345-009-0478-x. Epub 2009 Oct 14.